Zoom Journal Club 2019 con la collaborazione di AIRO giovani.

6 Feb 2019

Zoom Journal Club 2019 con la collaborazione di AIRO giovani.

Gennaio 2019. Functional Swallowing Units (FSUs) as organ-at-risk for radiotherapy. PART 1: Physiology and anatomy (a cura di Viola Salvestrini).

Febbraio 2019. Functional Swallowing Units (FSUs) as organ-at-risk for radiotherapy. PART 2: Physiology and anatomy (a cura di Viola Salvestrini)

Marzo 2019. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial (a cura di Stefania Martini e Giuseppe Carlo Iorio)

Aprile 2019. Bilateral vs ipsilateral adjuvant radiotherapy in patients with cancer of unknown primary of the head and neck: An analysis of the clinical outcome and radiation-induced side effects. (a cura di Giuseppe Carlo Iorio e Stefania Martini)

Maggio 2019. Individualized treatment of head neck squamous cell carcinoma patients aged 70 or older with radiotherapy alone or associated to cisplatin or cetuximab: impact of weekly radiation dose on loco-regional control. (a cura di Vincenzo Burgio)

Giugno 2019: Effectiveness of exercise-based rehabilitation on functional capacity and quality of life in head and neck cancer patients receiving chemo-radiotherapy (a cura di Vincenzo Burgio)

Luglio 2019. SPET:CT-guided elective nodal irradiation for head and neck cancer- estimation of clinical benefits using NTCP models. (A cura di Fernando Scala e Claudio Vitale)

Agosto 2019. Eliminating Postoperative Radiation to the Pathologically Node-Negative Neck: Long-Term Results of a Prospective Phase II Study. (a cura di Fernando Scala e Claudio Vitale)

Settembre 2019. 12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers ( a cura di Martina Venezia).

Ottobre 2019. Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: results from a phase – I trial ( a cura di Martina Venezia).

Novembre 2019. Triweekly carboplatin as a potential de-intensification agent in concurrent chemoradiation for early-stage HPV-associated oropharyngeal cancer (a cura di Simone Orelli).

Dicembre 2019. Gustatory disturbances occur in patients with head and neck cancer who undergo radiotherapy not directed to the oral cavity (a cura di Simone Orelli)

Condividi